Keyphrases
Antitumor Efficacy
100%
E6 Gene
100%
E7 Gene
100%
HPV16 E7
100%
Venezuelan Equine Encephalitis Virus
100%
Particle Encoding
100%
Virus Replicon Particle
100%
Tumor
25%
Vaccination
25%
High-risk Human Papillomavirus (HR-HPV)
25%
Tumor Challenge
25%
Epitope
25%
Oncogenic Potential
25%
E7 Protein
25%
Transgenic Mice
12%
Clinical Evaluation
12%
Associated Diseases
12%
Malignancy
12%
Immunogenicity
12%
Anti-tumor Response
12%
Cervical Cancer
12%
Challenge Model
12%
E6 Protein
12%
Upstream Open Reading Frame (uORF)
12%
T Cell Immunity
12%
P53 Protein
12%
Immunodominant
12%
Amino Acid Position
12%
Retinoblastoma Protein
12%
Cytotoxic T Cell Response
12%
Human Mammary Epithelial Cells
12%
Human Leukocyte antigen-A
12%
Model Protection
12%
TC-1 Tumor
12%
Pharmacology, Toxicology and Pharmaceutical Science
Human Papillomavirus Type 16
100%
Venezuelan Equine Encephalitis Virus
100%
Neoplasm
100%
Human Papillomavirus
50%
Protein E7
50%
Carcinogenesis
50%
Epitope
50%
Transgenic Mouse
25%
Clinical Trial
25%
Immunogenicity
25%
Protein P53
25%
Uterine Cervix Cancer
25%
Amino Acid
25%
Leukocyte Antigen
25%
Protein E6
25%
Retinoblastoma Protein
25%
Diseases
25%
Immunology and Microbiology
Venezuelan Equine Encephalitis Virus
100%
Human Papillomavirus Type 16
100%
Replicon
100%
Virus
75%
Epitope
25%
Wart Virus
25%
Cytotoxic T Cell
12%
Adoptive Immunity
12%
Immunogenicity
12%
Transgenic Mouse
12%
Human Leukocyte Antigen
12%
Wild Type
12%
T Cell
12%
P53
12%
Open Reading Frame
12%
Amino Acid
12%